Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq Capital Market on Tuesday. The initial public offering is estimated to gross US$6 million.

The offering consists of 1.0 million common shares, initially set at 3.0 million, selling at US$6.00 per share. The company is set to trade on the Nasdaq market under the symbol “HPCO”.

Boustead Securities acts as the sole bookrunner for the said offering, which is slated to close on September 1, 2022, subject to customary closing conditions.

The California-based firm makes CBD and hemp-based cigarettes, offering smokers a non-nicotine and tobacco alternative. The company aims to take on the US$1 trillion tobacco industry with its portfolio, including its own The Real Stuff functional hemp cigarette and rolling paper brand.


Information for this briefing was found via Edgar, Investment U, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Goliath Resources Extends High Grade Zone To 580 Metres In Latest Assays

Emerita Resources Hits 2.7% Copper, 1.85 g/t Gold Over 9.6 Metres At El Cura

Related News

Chinese Fund-Backed Marine SPAC Blue World Acquisition Prices US$80 Million IPO

Special purpose acquisition company Blue World Acquisition Corporation (Nasdaq: BWAQU) started trading publicly on the...

Tuesday, February 1, 2022, 02:28:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Railroad SPAC Integrated Rail and Resources Acquisition Prices US$200 Million IPO

Special purpose acquisition company Integrated Rail and Resources Acquisition Corp. (NYSE: IRRXU) went public today...

Friday, November 12, 2021, 02:10:00 PM

Financial SPAC HCM Acquisition Prices US$250 Million IPO

Special purpose acquisition company HCM Acquisition Corp (Nasdaq: HCMAU) started trading publicly on the Nasdaq...

Friday, January 21, 2022, 02:29:00 PM